Welcome! Our laboratory studies the mechanisms underlying complex neurodegenerative diseases, including Alzheimer’s Disease, Parkinson’s Disease and Frontotemporal Lobar Degeneration (FTLD). Our techniques range from cellular neurobiology to population studies and clinical trials. We’re interested in identifying new disease-related biological pathways, evaluating new experimental therapeutics, and developing new disease-specific biomarkers.
News
Dec 06, 2025 - Ted Wilson appointed to named chairTed Wilson named Provost’s Assistant Professor of Neuroimmunology and Brain Science.
Dec 01, 2025 - We’ve moved!The Wilson Lab has moved to Brown University! Contact us if you are interested in collaborating or joining our group of exceptional scientists!
Sep 03, 2025 - Ted and Bella were recently featured in Stanford’s Neuroscience NewsStanford undergrads and local community college students paired with Wu Tsai Neurosciences Institute researchers to find new ways to head off strokes, predict Alzheimer's disease, and more.
Aug 21, 2025 - Our work highlighted by Stanford University’s Knight Initiative for Brain ResilienceParkinson’s comes in many forms. New biomarkers may explain why.
Aug 01, 2024 - New Funding!Ted and Collaborator Prof. Birgitt Schuele in the Department of Pathology were recently a 2-year Catalyst Award from the Phil and Penny Knight Initiative for Brain Resilience.
Latest Publications
Do AN, Song S, Ali M, Timsina J, Wang L, Western D, Liu M, Sanford J, Rosende-Roca M, Boada M, Puerta R, Wilson EN, Ruiz A, Pastor P, ADNI, Wyss-Coray T & Cruchaga C “CSF proteomic profiling with amyloid and tau pathology identifies distinctive sex-specific alteration of multiple proteins involved in Alzheimer’s disease” Alzheimer’s & Dementia. 22(1):e71063 (2026). [PubMed]
Winer, JR, Vossler H, Young CB, Smith V, Romero A, Shahid-Besanti M, Abdelnour C, Wilson EN, Anders D, Pacheco Morales A, Andreasson KI, Yutsis MV, Henderson VW, Davidzon GA, Mormino EC, Poston KL “18F-PI-2620 Tau PET is associated with cognitive and motor impairment in Lewy body disease” Brain Communications. 7(1) (2025). [PubMed]
Oh HS, Urey DY, Karlsson L, Zhu Z, Shen Y, Farinas A, Timsina J, Duggan MR, Chen J, Guldner IH, Morshed N, Yang C, Western D, Ali M, Le Guen Y, Trelle A, Herukka SK, Rauramaa T, Hiltunen M, Lipponen A, Luikku AJ, Poston KL, Mormino E, Wagner AD, Wilson EN, Channappa D, Leinonen V, Stevens B, Ehrenberg AJ, Gottesman RF, Coresh J, Walker KA, Zetterberg H, Bennett DA, Franzmeier N, Hansson O, Cruchaga C, Wyss-Coray T “A Cerebrospinal Fluid Synaptic Protein Biomarker for Prediction of Resilience Versus Decline in Alzheimer’s Disease” Nature Medicine. 31:1592-1603 (2025). [PubMed]
Grandke F, Fehlmann T, Kern F, Gate DM, Wolff TW, Leventhal O, Channappa D, Hirsh P, Wilson EN, Meese E, Liu C, Shi Q, Flotho M, Lil Y, Chen C, Yu Y, Xu J, Junkin M, Wang Z, Wu T, Liu L, Hou Y, Andreasson KI, Gansen JS, Mass E, Poston KL, Wyss-Coray T, Keller A “A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegeneration” Nature Communications. 16 (1): 1965 (2025).
